Continuing Education  » Oncology  » Lymphoma: The state of this disease in dogs and how epigenetics may open future doors

Lymphoma: The state of this disease in dogs and how epigenetics may open future doors

CE Event Information

  • Description:
    Join us in this session and learn about the current state of diagnosis and treatment of canine lymphoma.  Discussion includes: the prognostic significance of lymphoma type, how the type influences treatment decisions, current therapies that are employed, and what the future might hold for new treatments for the disease.  Finally, we discuss what epigenetics are, the relevance to their study in cancers like lymphoma, and how they may influence future disease understanding.

    At the conclusion of the lecture, the attendee will understand:

    - Broad categories of canine lymphoma
    - Current therapies for these categories
    - Emerging new therapies
    - The significance of DNA methylation in the development of cancer
    - How DNA methylation might impact risk assessment, diagnosis, and treatment

    (Running time: 42 mins, followed by 13 mins of Q and A with Dr. Jeffrey Bryan)

    Registration is compliments of the AKC Canine Health Foundation
  • Sponsor: AKC Canine Health Foundation
  • Presenter(s): Jeffrey N. Bryan, DVM, MS, PhD, DACVIM (Oncology)


Featured Publications


The following journal articles or textbook chapters have been selected as Supplements to this event. You can elect to purchase them as part of a discounted seminar package fee.
Prepaid CE Subscribers will be assessed a supplement fee for articles purchased.

  • Supportive Care for the Cancer Patient

    Withrow and MacEwen's Small Animal Clinical Oncology (Fifth Edition), 2013, Chapter 15, Pages 245-279. Member fee: $7.95 - Login to purchase
  • Preparation of Cytology Samples: Tricks of the Trade

    Veterinary Clinics of North America: Small Animal Practice, Vol 47(1), January 2017, Pages 1-16. Author: A Russell Moore Basic Member Fee: $...  more
  • Nutritional Care of Cancer Patients

    Canine and Feline Nutrition (3rd Ed), 2011, Chapter 36, pp 479-489. Authors: Linda P. Case, Leighann Daristotle, Michael G. Hayek, Melody Fo...  more

 There is a growing demand for use of integrative medicine in veterinary clinical oncology.

  •  Evidence-based research on using integrative medicine in veterinary clinical oncology is

    scarce.

  •  Translational research with animal models of human cancers is an opportunity to expand the knowledge of the etiopathogenesis of neoplasia and identify treatments.

  •  Metabolomics research may provide the evidence-based research needed to accelerate the use of complementary and alternative medicine in both human and veterinary oncology.


    HERBS/BOTANICS EVALUATED IN DOGS OR IN VITRO CANINE CELLS

    HERBS/BOTANICS EVALUATED IN VIVO OR IN VITRO IN OTHER SPECIES

    Herbs that have been evaluated in vivo and/or in vitro in species other than dogs

    BIOACTIVE POLYSACCHARIDES: FUNGI

    ACUPUNCTURE

    DIETARY SUPPLEMENTS EVALUATED IN DOGS OR IN VITRO CANINE CELLS AND RELEVANT STUDIES IN OTHER SPECIES OR IN VITRO

    Calcitriol

    Retinoids

    Antioxidants

    Omega-3 Fatty Acids

    Probiotics

    Phytic Acid, Phytate, Myo-Inositol Hexaphosphate

    USING IM IN VETERINARY CLINICAL ONCOLOGY

    Evidence-based Integrative Medicine in Clinical Veterinary Oncology

    ADVERSE REACTIONS: DRUG-HERB INTERACTIONS

    Resources

    References

     


    Veterinary Clinics of North America: Small Animal Practice, Vol 44(50, September 2014, pp 831-853. Authors: Donna M. Raditic, Joseph W. Bart...  more